These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 659632)

  • 1. Neutralization of glucagon by antiserum as a tool in glucagon physiology. Lack of depression of basal blood glucose after antiserum treatment in rats.
    Holst JJ; Galbo H; Richter EA
    J Clin Invest; 1978 Jul; 62(1):182-90. PubMed ID: 659632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study of the physiological role of glucagon. Passive immunization with antiserum specific for pancreatic glucagon in rats.
    Nishino T; Shima K; Shimomura Y; Tanaka R; Kodaira T; Imagawa K; Kumahara Y
    Endocrinol Jpn; 1980 Dec; 27 Suppl 1():109-13. PubMed ID: 7227314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma glucagon and insulin in rat pregnancy. Roles in glucose homeostasis.
    Saudek CD; Finkowski M; Knopp RH
    J Clin Invest; 1975 Jan; 55(1):180-7. PubMed ID: 1109177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of glucagon antibodies on plasma glucose, insulin and somatostatin in the fasting and fed rat.
    Tan K; Tsiolakis D; Marks V
    Diabetologia; 1985 Jul; 28(7):435-40. PubMed ID: 2864300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of hypothermia on the insulin--receptor interaction in liver plasma membranes.
    Torlińska T; Nowak KW; Kozlik J; Paluszak J
    J Physiol Pharmacol; 1993 Dec; 44(4):399-408. PubMed ID: 8123887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucagon-like peptide-1 can reverse the age-related decline in glucose tolerance in rats.
    Wang Y; Perfetti R; Greig NH; Holloway HW; DeOre KA; Montrose-Rafizadeh C; Elahi D; Egan JM
    J Clin Invest; 1997 Jun; 99(12):2883-9. PubMed ID: 9185511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of glucagon in maintenance of euglycemia in fed and fasted rats.
    Brand CL; Jørgensen PN; Knigge U; Warberg J; Svendsen I; Kristensen JS; Holst JJ
    Am J Physiol; 1995 Sep; 269(3 Pt 1):E469-77. PubMed ID: 7573424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycogenolytic responsiveness to glucagon, epinephrine, vasopressin and angiotensin II in the liver of developing hypothyroid rats. A comparative study of in vitro hormonal binding and in vivo biological response.
    Ali M; Cantau B; Clos J
    J Dev Physiol; 1989 Jun; 11(6):360-7. PubMed ID: 2592754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased responses of glucagon and glucose production to hypoglycemia with intraperitoneal versus subcutaneous insulin treatment.
    Wan CK; Giacca A; Matsuhisa M; El-Bahrani B; Lam L; Rodgers C; Shi ZQ
    Metabolism; 2000 Aug; 49(8):984-9. PubMed ID: 10954014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of glucagon on glucose production during insulin deficiency in the dog.
    Cherrington AD; Lacy WW; Chiasson JL
    J Clin Invest; 1978 Sep; 62(3):664-77. PubMed ID: 690190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of insulin and glucagon in the regulation of basal glucose production in the postabsorptive dog.
    Cherrington AD; Chiasson JL; Liljenquist JE; Jennings AS; Keller U; Lacy WW
    J Clin Invest; 1976 Dec; 58(6):1407-18. PubMed ID: 993351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of glucose turnover during exercise in pancreatectomized, totally insulin-deficient dogs. Effects of beta-adrenergic blockade.
    Bjorkman O; Miles P; Wasserman D; Lickley L; Vranic M
    J Clin Invest; 1988 Jun; 81(6):1759-67. PubMed ID: 3290252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of glucagon secretion.
    Young A
    Adv Pharmacol; 2005; 52():151-71. PubMed ID: 16492545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutralization of endogenous glucagon by high titer glucagon antiserum.
    Grey N; McGuigan JE; Kipnis DM
    Endocrinology; 1970 Jun; 86(6):1383-8. PubMed ID: 5441872
    [No Abstract]   [Full Text] [Related]  

  • 15. Stripping of endogenous ligands from antisera against glucagon.
    Grønholt R; Holst JJ
    J Immunol Methods; 1983 Mar; 58(1-2):83-91. PubMed ID: 6833768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High titer glucagon antisera.
    Tager HS; Hohenboken M; Markese J
    Endocrinology; 1977 Feb; 100(2):367-72. PubMed ID: 832629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A modification of the unlabeled antibody enzyme method using heterologous antisera for the light microscopic and ultrastructural localization of insulin, glucagon and growth hormone.
    Erlandsen SL; Parsons JA; Burke JP; Redick JA; Van Orden DE; Van Orden LS
    J Histochem Cytochem; 1975 Sep; 23(9):666-77. PubMed ID: 1176760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production and characterization of an antiserum against pancreatic glucagon.
    Von Schenck H
    Clin Chim Acta; 1977 Nov; 80(3):455-63. PubMed ID: 912916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physiological effect of circulating glucagon on the hepatic membrane potential.
    Lutz TA; Estermann A; Geary N; Scharrer E
    Am J Physiol Regul Integr Comp Physiol; 2001 Nov; 281(5):R1540-4. PubMed ID: 11641126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucagon antiserum: a tool to investigate the role of circulating glucagon in obese-hyperglycaemic (ob/ob) mice [proceedings].
    Flatt PR; Swanston-Flatt SK; Bailey CJ
    Biochem Soc Trans; 1979 Oct; 7(5):911-3. PubMed ID: 510739
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.